Imaging Infrastructure for the Digital OR

UX7 Series Endoscope Camera System (4K, NIR Fluorescence & 3D)

Minimally invasive surgery has long been constrained by the trade-off between image quality and real-time guidance. The UX7 Series addresses this by integrating true 4K resolution, near-infrared fluorescence, and real-time 3D visualization into a single camera head and control platform. For the surgeon, this means fewer gaze shifts between monitors and less mental load interpreting anatomical boundaries.

The technical foundation is dual-chip 4K sensors paired with image algorithms that manage HDR, detail enhancement, and brightness equalization. Auto-focus and active anti-fog heating maintain clarity without manual intervention. Fluorescence imaging operates in the NIR spectrum, enabling real-time assessment of vascular perfusion—a critical capability in oncology and reconstructive procedures.

Modularity is the system’s operational logic. The UX7 supports 10 mm, 5 mm, and 3 mm rigid endoscopes, 0° and 30° viewing angles, and both 32″ and 55″ 4K monitors. The camera head weighs between 190 g and 240 g depending on configuration, reducing arm fatigue during lengthy interventions. Dual-channel recording and PACS integration ensure the platform fits existing hospital IT workflows.

China’s role here is not just as manufacturer but as integrator. The UX7’s full-chain R&D—from sensor to software to sterilization compatibility—suggests a domestic supply chain capable of producing a complete surgical imaging stack. That reduces procurement complexity for Chinese hospitals and positions the system for export markets seeking cost-competitive alternatives to established Japanese and German brands.

What makes the UX7 notable is not any single specification but the reduction in system friction. Fewer components to source, fewer compatibility checks, a single operator interface. In a digital operating room, that simplicity is its own kind of performance metric.

Why it matters:
For hospital procurement teams, the UX7 reduces vendor management overhead and training costs. For surgeons, it collapses three imaging modalities into one workflow. For China’s medtech ecosystem, it signals that domestic platforms can now compete on integration, not just price.

View Product →